State Street’s Catheter Precision VTAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1
Closed -$1K 4894
2022
Q3
$1K Hold
1
﹤0.01% 4930
2022
Q2
$4K Hold
1
﹤0.01% 4941
2022
Q1
$4K Hold
1
﹤0.01% 4914
2021
Q4
$16K Hold
1
﹤0.01% 4784
2021
Q3
$32K Hold
1
﹤0.01% 4669
2021
Q2
$45K Buy
+1
New +$41.6K ﹤0.01% 4434

Other funds holding VTAK

State Street's VTAK Position: Q4 2022 in Review

State Street sold out of Catheter Precision (VTAK) in Q4 2022, closing a stake of 1 share — an estimated $1K sold.

State Street first reported a position in VTAK in Q2 2021 and held it in 6 quarters. The position peaked at $45K in Q2 2021. 9 funds tracked by Wall St. Rank hold VTAK as of Q4 2022.

  • State Street reported no remaining Catheter Precision position as of Q4 2022 after selling out during the quarter.
  • State Street sold 1 Catheter Precision share in Q4 2022, an estimated $1K.
  • State Street first reported a position in Catheter Precision in Q2 2021 and held it in 6 quarters.
  • State Street's Catheter Precision position peaked at $45K in Q2 2021.
  • 9 funds tracked by Wall St. Rank held Catheter Precision as of Q4 2022.

Based on State Street's 13F filing for Q4 2022, filed 14 Feb 2023.